Late Stage and Merger & Acquisitions

Ferring’s Business Development team focuses on late stage compounds that are ready to go to phase IIb as well as on product and company acquisitions.

Please contact Global Business Development according to the following therapeutic areas or regions:

Devices, orthopaedics and/or USA and Canada	Edgar Koster Senior Vice President, Global Operations Phone +41 76 301 02 02 (Switzerland) email
Reproductive Health, New Therapeutic Areas and/or Europe	Jan Honoré Senior Director, Global Business Development Phone +41 58 301 00 00 (Switzerland) email
Gastro, Endocrinology, Urology and/or Asia, Middle East, Latin America	David Benathan Director, Global Business Development Phone +41 58 301 00 00 (Switzerland) email

Your name* This field is required Your email address* This field is required

Recipient's email address* This field is required

By using the service, you agree to the following:

Your email address and the recipient's email address will be used for transmission purposes only - to inform the addressee about the sender, or for sending a message in the event of a transmission error. Both email addresses will be deleted from our system after a short period.

Share this page

Late Stage and Merger & Acquisitions

The message has been sent